Zoll Medical, one of the makers of Defibrillator products announced today that the U.S. Food and Drug Administration has approved a new version of it’s LifeVest product. The Zoll LifeVest is worn by patients at risk for sudden cardiac arrest. Zoll said more than 2,000 patients are currently using the product. Zoll said it is increasing its inventory to support further growth.

The LifeVest is mainly worn by those of very high-risk of having cardiac arrest!

The LifeVest is worn outside of the body rather than having to be implanted in the chest. Reasons could be for the risk of surgery or patient preference.

The Zoll LifeVest consist of two main pieces to the defibrillator:

An electrode belt and garment that surrounds the patient’s chest and A monitor the patient puts around their waist or wears as a shoulder strap.

For more information see: Zoll LifeVest.